mRNA疗法，成功恢复先天不育雄性的生育能力

Core Viewpoint - The article discusses a new mRNA-based therapy that restores fertility in congenitally infertile male mice by targeting Sertoli cells without introducing genetic material into germ cells, presenting a safer alternative to traditional gene therapy methods [3][6][8]. Group 1: Mechanism of Male Infertility - Male infertility often arises from impaired interactions between germ cells and Sertoli cells, which are crucial for sperm development [5]. - Sertoli cells provide essential factors and nutrients for spermatogenesis and establish the blood-testis barrier (BTB), which is vital for creating an optimal environment for meiosis [5]. - Abnormal interactions between germ cells and Sertoli cells can lead to meiotic arrest, resulting in male infertility, which cannot be treated by IVF or ICSI [5]. Group 2: mRNA Therapy Research Findings - Researchers successfully delivered mRNA to the testes of genetically infertile mice, restoring their fertility by enabling spermatogenesis [6]. - The mRNA specifically expressed in Sertoli cells, leading to the development of spermatocytes from spermatogonia, despite triggering a mild innate immune response [6]. - The study demonstrated that healthy offspring with normal imprinting patterns were produced through in vitro fertilization techniques from the treated mice [6][8]. Group 3: Implications of the Study - The findings indicate that mRNA-based therapies targeting somatic cells in the testes offer a novel approach to treating male infertility without the risks associated with traditional gene therapy [8].